NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Jadad AR, Boyle M, Cunningham C, et al. Treatment of Attention-Deficit/Hyperactivity Disorder. Rockville (MD): Agency for Healthcare Research and Quality (US); 1999 Nov. (Evidence Reports/Technology Assessments, No. 11.)
This publication is provided for historical reference only and the information may be out of date.
- Supplemental Evidence Tables - Treatment of Attention-Deficit/Hyperactivity Diso...Supplemental Evidence Tables - Treatment of Attention-Deficit/Hyperactivity Disorder
- Summary - Treatment of Attention-Deficit/Hyperactivity DisorderSummary - Treatment of Attention-Deficit/Hyperactivity Disorder
- Mus musculus dopa decarboxylase (Ddc), transcript variant 2, mRNAMus musculus dopa decarboxylase (Ddc), transcript variant 2, mRNAgi|2451183842|ref|NM_016672.5|Nucleotide
- RecName: Full=Aromatic-L-amino-acid decarboxylase; Short=AADC; AltName: Full=DOP...RecName: Full=Aromatic-L-amino-acid decarboxylase; Short=AADC; AltName: Full=DOPA decarboxylase; Short=DDCgi|6685369|sp|O88533.1|DDC_MOUSEProtein
Your browsing activity is empty.
Activity recording is turned off.
See more...